Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice

Antiviral Research

Volumn 91, Issue 2, 2011, Pages 154-160

  Lipipun, Vimolmas ^a   Sasivimolphan, Pattaraporn ^a   Yoshida, Yoshihiro ^b   Daikoku, Tohru ^b   Sritularak, Boonchoo ^a   Ritthidej, Garnpimol ^a   Likhitwitayawuid, Kittisak ^a   Pramyothin, Pornpen ^a   Hattori, Masao ^b   Shiraki, Kimiyasu ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cream; Cutaneous infection in mice; Herpes simplex virus; Oxyresveratrol; Therapeutic efficacy

Indexed keywords

ACICLOVIR; OXYRESVERATROL; PETROLATUM; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREAM; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ISOLATION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOPICAL TREATMENT; VIRAL SKIN DISEASE; VIRUS INHIBITION;

ACYCLOVIR; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIVIRAL AGENTS; ARTOCARPUS; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; INHIBITORY CONCENTRATION 50; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLAQUE ASSAY; SKIN DISEASES, INFECTIOUS; STILBENES; VERO CELLS;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; MUS; SIMPLEXVIRUS;

EID: 79959221646     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.05.013     Document Type: Article

References (25)

1. Chuanasa T., Phromjai J., Lipipun V., Likhitwitayawuid K., Suzuki M., Pramyothin P., Hattori M., Shiraki K. Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice. Antiviral Res. 2008, 80(1):62-70.
2. De Clercq, E., 1984. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds. Antimicrob. Agents Chemother. 155-159.
3. De Clercq E. Molecular targets for antiviral agents. J. Pharmacol. Exp. Ther. 2001, 297:1-10.
4. De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30:115-133.
5. Galasso G.J., Whitley R.J., Merigan T.C. Antiviral Agents and Human Viral Diseases 1997, Lippincott-Raven, Philadelphia.
6. Giirol Z., Hekimoglu S., Demirdamar R., Sumnu M. Percutaneous absorption of ketoprofen. I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases. Pharm. Acta Helvetiae 1996, 71:205-212.
7. Greco A., Diaz J.J., Thouvenot D., Morfin F. Novel targets for the development of anti-herpes compounds. Infect. Disord. Drug Targets 2007, 7:11-18.
8. Herold B.C., Gerber S.I., Polonsky T., Belval B.J., Shaklee P.N., Holme K. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology 1995, 206:1108-1116.
9. Khan M.T.H., Ather A., Thompson K.D., Gambari R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res. 2005, 67:107-119.
10. Kurokawa M., Ochiai H., Nagasaka K., Neki M., Xu H., Kadota S., Sutardjo S., Matsumoto T., Namba T., Shiraki K. Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res. 1993, 22:175-188.
11. Kurokawa M., Hozumi T., Basnet P., Nakano M., Kadota S., Namba T., Kawana T., Shiraki K. Purification and characterization of eugeniin as an anti-herpes virus compound from Geum japonicum and Syzygium aromaticum. J. Pharmacol. Exp. Ther. 1998, 284:728-735.
12. Kurokawa M., Basnet P., Ohsugi M., Hozumi T., Kadota S., Namba T., Kawana T., Shiraki K. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. J. Pharmacol. Exp. Ther. 1999, 289:72-78.
13. Likhitwitayawuid K., Sritularak B., Benchanak K., Lipipun V., Mathew J., Schinazi R.F. Phenolics with antiviral activity from Millettia erythrocalyx and Artocarpus lakoocha. Nat. Prod. Res. 2005, 19:177-182.
14. Lipipun V., Kurokawa M., Suttisri R., Taweechotipatr P., Pramyothin P., Hattori M., Shiraki K. Efficacy of Thai medicinal plant extracts against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res. 2003, 60:175-180.
15. Sangkitporn S., Polihan K., Thawatsupa P., Bunchok M., Chawalitthumrong P. Treatment of recurrent genital herpes simplex virus infections with Clinacanthus nutans extract. Bull. Dept. Med. Serv. 1993, 18:226-231.
16. Sangkitporn S., Chaiwat S., Balachandra K., Na-Ayudhaya T.D., Bunjob M., Jayavasu C. Treatment of herpes zoster with Clinacanthus nutans (BiPhya Yaw) extract. J. Med. Assoc. Thai 1995, 78:624-627.
17. Sasivimolphan P., Lipipun V., Likhitwitayawuid K., Takemoto M., Pramyothin P., Hattori M., Shiraki K. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro. Antiviral Res. 2009, 84:95-97.
18. Shiraki K., Rapp F. Effects of caffeine on herpes simplex virus. Intervirology 1988, 29:235-240.
19. Shiraki K., Ishibashi M., Okuno T., Namazue J., Yamanishi K., Sonoda T., Takahashi M. Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in vitro. Arch. Virol. 1991, 117:165-171.
20. Spruance S.L., Freeman D.J., Sheth N.V. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection. Antimicrob. Agents Chemother. 1986, 30:196-198.
21. Spurance S.L., Freeman D.J. Topical treatment of cutaneous herpes simplex virus infections. Antiviral Res. 1990, 14:305-321.
22. Sritularak B., De-Eknamkul W., Likhitwitayawuid K. Tyrosinase inhibitors from Artocarpus lakoocha. Thai J. Pharm. Sci. 1998, 22:149-155.
23. Suzuki M., Okuda T., Shiraki K. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus. Antiviral Res. 2006, 72:157-161.
24. Tennican P., Carl G., Frey J., Thies C., Chvapil M. Topical zinc in the treatment of mice infected intravaginally with herpes genitalis virus. Proc. Soc. Exp. Biol. Med. 1980, 164:593-597.
25. Vanden Berghe D.A., Haemers A.R., Vlietinck A.J. Antiviral agents from higher plants and an example of structure-activity relationship of 3-methoxy flavones. Bioactive Natural Product: Detection, Isolation and Structural Determination 1993, 405-440. CRC Press, Boca Raton. S.M. Colgate, R.J. Molyneux (Eds.).